Literature DB >> 29657060

Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke.

Cheng-Yang Hsieh1, Cheng-Han Lee2, Darren Philbert Wu3, Sheng-Feng Sung4.   

Abstract

BACKGROUND: It is unclear whether ischemic stroke patients with known atrial fibrillation (KAF) had different outcomes than those with atrial fibrillation diagnosed after stroke (AFDAS). We aimed to explore the characteristics and outcomes in ischemic stroke patients with KAF or AFDAS.
METHODS: Consecutive patients hospitalized between 2000 and 2012 for first-ever stroke along with atrial fibrillation, either diagnosed before or during the stroke hospitalization, were identified from a nationwide claims database in Taiwan. The outcome of interest was a composite outcome of ischemic stroke, intracranial hemorrhage, or death within one year. Univariable and multivariable Cox regression analyses were used to determine the effect of KAF versus AFDAS on the composite outcome.
RESULTS: We identified 1161 patients, of whom 481 (41.4%) had KAF and 680 (58.6%) had AFDAS. Age, sex, and stroke severity were similar between groups. However, patients with KAF had a higher prevalence of underlying heart diseases than those with AFDAS (67.2% versus 39.0%, p<0.001). In univariable analysis, patients with KAF had a higher risk of the composite outcome than those with AFDAS (hazard ratio [HR]: 1.42, 95% confidence interval [CI]: 1.13-1.79, p=0.003). In multivariable analysis, KAF was no longer independently associated with the composite outcome.
CONCLUSIONS: As compared to ischemic stroke patients with AFDAS, those with KAF had a higher prevalence of underlying heart diseases. Whether AF was known before or diagnosed after stroke was not an independent predictor of the composite outcome.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Diagnosis; Ischemic stroke; Outcomes

Mesh:

Year:  2018        PMID: 29657060     DOI: 10.1016/j.ijcard.2017.11.047

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.

Authors:  David J Seiffge; Gian Marco De Marchis; Masatoshi Koga; Maurizio Paciaroni; Duncan Wilson; Manuel Cappellari; Kosmas Macha Md; Georgios Tsivgoulis; Gareth Ambler; Shoji Arihiro; Leo H Bonati; Bruno Bonetti; Bernd Kallmünzer; Keith W Muir; Paolo Bovi; Henrik Gensicke; Manabu Inoue; Stefan Schwab; Shadi Yaghi; Martin M Brown; Philippe Lyrer; Masahito Takagi; Monica Acciarrese; Hans Rolf Jager; Alexandros A Polymeris; Kazunori Toyoda; Michele Venti; Christopher Traenka; Hiroshi Yamagami; Andrea Alberti; Sohei Yoshimura; Valeria Caso; Stefan T Engelter; David J Werring
Journal:  Ann Neurol       Date:  2020-02-12       Impact factor: 10.422

2.  Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke.

Authors:  Jin-Yi Hsu; Peter Pin-Sung Liu; Luciano A Sposato; Huei-Kai Huang; An-Bang Liu; Edward Chia-Cheng Lai; Swu-Jane Lin; Cheng-Yang Hsieh; Ching-Hui Loh
Journal:  Front Cardiovasc Med       Date:  2022-07-22

3.  Phenotypes of atrial fibrillation diagnosed before-versus-after ischaemic stroke and TIA: study protocol for a systematic review and meta-analysis.

Authors:  Amado Jimenez-Ruiz; Juan Camilo Vargas-Gonzalez; Sebastian Fridman; Luciano A Sposato
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

4.  A web based dynamic MANA Nomogram for predicting the malignant cerebral edema in patients with large hemispheric infarction.

Authors:  Wenzhe Sun; Guo Li; Yang Song; Zhou Zhu; Zhaoxia Yang; Yuxi Chen; Jinfeng Miao; Xiaoyan Song; Yan Lan; Xiuli Qiu; Suiqiang Zhu; Yebin Fan
Journal:  BMC Neurol       Date:  2020-09-29       Impact factor: 2.474

5.  Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018.

Authors:  Brent A Williams; Alanna M Chamberlain; James C Blankenship; Elaine M Hylek; Stephen Voyce
Journal:  JAMA Netw Open       Date:  2020-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.